Home › Funds › OCCUDO QUANTITATIVE STRATEGIES LP › RPRX
OCCUDO QUANTITATIVE STRATEGIES LP position in RPRX
ROYALTY PHARMA PLC · Health Care
OCCUDO QUANTITATIVE STRATEGIES LP reported holding 165,177 shares of RPRX (ROYALTY PHARMA PLC) in its Q2 2026 13F filing — a position valued at US$9.3M, representing 0.49% of its reported portfolio and ranking #42 among its reported holdings. OCCUDO QUANTITATIVE STRATEGIES LP has disclosed RPRX holdings in 5 of the last 8 reported quarters, going back to Q3 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How OCCUDO QUANTITATIVE STRATEGIES LP's RPRX position evolved
OCCUDO QUANTITATIVE STRATEGIES LP first disclosed a stake in RPRX in Q3 2024 at 11,460 shares (US$324K). The position peaked in Q2 2026 at 165,177 shares, worth US$9.3M. Across 5 filings, OCCUDO QUANTITATIVE STRATEGIES LP increased the stake 3 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 165,177 shares valued at US$9.3M — an increase of 43,377 shares quarter over quarter.. Notable position changes include a 96% increase in Q4 2024 (shares rose 22% over the following quarter), a 248% increase in Q1 2025 (shares rose 16% over the following quarter), a 36% increase in Q2 2026 (shares rose 4% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2024 | 11.46K | $324.20K | New |
| Q4 2024 | 22.51K | $574.28K | Add |
| Q1 2025 | 78.38K | $2.46M | Add |
| Q1 2026 | 121.80K | $6.10M | New |
| Q2 2026 | 165.18K | $9.26M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About RPRX and 13F data
RPRX (ROYALTY PHARMA PLC) is a Health Care company. 50 other funds we track also report a position in RPRX — the largest reported positions include Swedbank AB (US$601.4M), Baillie Gifford & Co (US$561.6M), Caledonia (Private) Investments Pty Ltd (US$323.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding RPRX
- Swedbank AB 10.73M sh · $601.44M · Q2 2026
- Baillie Gifford & Co 10.02M sh · $561.57M · Q2 2026
- Caledonia (Private) Investments Pty Ltd 5.78M sh · $323.85M · Q2 2026
- ROYAL LONDON ASSET MANAGEMENT LTD 4.32M sh · $242.20M · Q2 2026
- Patient Capital Management, LLC 3.60M sh · $201.79M · Q2 2026
- Dorsey Asset Management, LLC 2.46M sh · $137.74M · Q2 2026
- Regal Partners Ltd 2.45M sh · $137.25M · Q2 2026
- NEW SOUTH CAPITAL MANAGEMENT INC 2.39M sh · $133.78M · Q2 2026
- Clark Capital Management Group, Inc. 1.66M sh · $93.24M · Q2 2026
- HOMESTEAD ADVISERS CORP 1.66M sh · $92.92M · Q2 2026
- EVENTIDE ASSET MANAGEMENT, LLC 1.38M sh · $77.67M · Q2 2026
More on OCCUDO QUANTITATIVE STRATEGIES LP
FAQ
How long has OCCUDO QUANTITATIVE STRATEGIES LP held RPRX?
OCCUDO QUANTITATIVE STRATEGIES LP has disclosed RPRX holdings in 5 of the last 8 reported quarters, going back to Q3 2024.
What is OCCUDO QUANTITATIVE STRATEGIES LP's current position in RPRX?
As of Q2 2026, OCCUDO QUANTITATIVE STRATEGIES LP holds 165.18K shares of RPRX (ROYALTY PHARMA PLC), valued at $9.26M, representing 0.49% of its reported portfolio and ranking #42.
Has OCCUDO QUANTITATIVE STRATEGIES LP been buying or selling RPRX?
In the latest 13F filing (Q2 2026), OCCUDO QUANTITATIVE STRATEGIES LP increased its position in RPRX. The position peaked in Q2 2026 at 165.18K shares.
Which other funds hold RPRX?
Other major institutional holders of RPRX include Swedbank AB, Baillie Gifford & Co, Caledonia (Private) Investments Pty Ltd, among 50 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.